 Connection
Heidi Day to Oxidopamine
This is a "connection" page, showing publications Heidi Day has written about Oxidopamine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.120 |
|
|
|
-
Day HE, Vittoz NM, Oates MM, Badiani A, Watson SJ, Robinson TE, Akil H. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res. 2002 Aug 02; 945(2):151-9.
Score: 0.047
-
Day HE, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ, Akil H. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci. 2001 Jan 15; 21(2):732-40.
Score: 0.042
-
Ostrander MM, Badiani A, Day HE, Norton CS, Watson SJ, Akil H, Robinson TE. Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. Neuroscience. 2003; 120(2):551-71.
Score: 0.012
-
Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res. 1999 Sep; 103(2):203-9.
Score: 0.010
-
Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci. 1998 Dec 15; 18(24):10579-93.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|